Buscar
01/12/2025
Exploring the relationship between maternal carbohydrate quality and quantity during pregnancy and early childhood neurodevelopment: a prospective cohort study within the BiSC cohort
Panisello, L, Mateu-Fabregat, J, Novau-Ferré, N, Ayala-Aldana, N, Bernardo-Castro, S, Ferrer, M, Jiménez-Arenas, P, Llurba, E, Lassale, C, Gomez-Roig, MD, Vioque, J, González-Palacios, S, Contreras-Rodríguez, O, Foraster, M, Gascon, M, Sunyer, J, Awad, C, Júlvez, J, Bullo, M. Exploring the relationship between maternal carbohydrate quality and quantity during pregnancy and early childhood neurodevelopment: a prospective cohort study within the BiSC cohort. EUROPEAN JOURNAL OF NUTRITION. 2025; 64(8)DOI:10.1007/s00394-025-03829-0. PMID:41324685. IF:4.300(Q1/3D).
01/12/2025
Immunotherapy or Targeted Therapy Versus Best Supportive Care for Advanced Gastric Cancer: A Systematic Review and Meta-analysis of Randomized Trials
Meade, A, Santero, M, Savall-Esteve, O, Bracchiglione, J, Leache, L, Selva, A, Macias, I, Cerdà, P, Cosp, XB. Immunotherapy or Targeted Therapy Versus Best Supportive Care for Advanced Gastric Cancer: A Systematic Review and Meta-analysis of Randomized Trials. Journal Of Gastrointestinal Cancer. 2025; 56(1)DOI:10.1007/s12029-024-01155-y. PMID:40032744. IF:(Q/D).
01/12/2025
Comparative effectiveness of noninvasive ventilation interfaces in critically ill adults: A systematic review and Bayesian network meta-analysis
Garcia, BMSP, Vieira, AGD, Pinto, ACPN, Eid, RAC, Genta, PR, Mól, CG, Nawa, RK. Comparative effectiveness of noninvasive ventilation interfaces in critically ill adults: A systematic review and Bayesian network meta-analysis. Intensive and Critical Care Nursing. 2025; 91DOI:10.1016/j.iccn.2025.104202. PMID:40848550. IF:4.700(Q1/1D).
01/12/2025
West Nile virus transmission in the Metropolitan Area of Barcelona (Spain): A One-Health surveillance approach
Busquets, N, Gardela, J, José-Cunilleras, E, Solé, A, Salvador, MJ, Obón, E, Molina-López, R, Aranda, C, Montalvo, T, Corbella, I, Bou-Monclús, MA, Martínez, MJ, Vázquez, A, Piron, M, Sauleda, S, Pailler-García, L, Napp, S. West Nile virus transmission in the Metropolitan Area of Barcelona (Spain): A One-Health surveillance approach. One Health. 2025; 21DOI:10.1016/j.onehlt.2025.101150. PMID:40746420. IF:4.500(Q1/1D).
01/12/2025
Framework and accreditation criteria of Web Médica Acreditada: Consolidating 25 years of development
Wisen, GT, Casasa, A, Perez, MM, Selma, JPI. Framework and accreditation criteria of Web Médica Acreditada: Consolidating 25 years of development. MEDICINA CLINICA. 2025; 165(6)DOI:10.1016/j.medcli.2025.107141. PMID:. IF:2.100(Q2/3D).
01/12/2025
Electroencephalographic manifestations of intracranial hypertension in a patient with ventriculoperitoneal shunt malfunction
Bernardi, E, Ros-Castello, V, Coronel-Coronel, M, Lazzari, R, Aibar-Durán, JA, Sierra-Marcos, A. Electroencephalographic manifestations of intracranial hypertension in a patient with ventriculoperitoneal shunt malfunction. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. 2025; 133DOI:10.1016/j.seizure.2025.10.017. PMID:41175508. IF:2.800(Q2/5D).
01/12/2025
Lipomatous metaplasia in cardiac CT: when 'normal' extracellular volume does not indicate myocardial viability - a case report
Pieszko, K, González, CR, Petracca, RL, Medel, DV. Lipomatous metaplasia in cardiac CT: when 'normal' extracellular volume does not indicate myocardial viability - a case report. European Heart Journal-Case Reports. 2025; 9(12)DOI:10.1093/ehjcr/ytaf612. PMID:41384087. IF:(Q/D).
01/12/2025
Guideline-directed medical therapy after revascularization and outcomes in ischaemic cardiomyopathy
Moliner-Abos, C, Calvo-Barcelo, M, Solé-Gonzalez, E, Martín, AB, Brugués, PF, Vega, JS, Jubany, JV, Vallverdú, MF, Ferrer, MT, Castillo, PET, Mancera, JCD, Rigau, PV, Olives, RV, Lopez, CD, Bayés-Genís, A, Aizpurua, DA, González, IF, Pérez, SM. Guideline-directed medical therapy after revascularization and outcomes in ischaemic cardiomyopathy. ESC Heart Failure. 2025; 12(6)DOI:10.1002/ehf2.70014. PMID:41243815. IF:3.700(Q1/3D).
01/12/2025
Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial
Salinas, P, Romaguera, R, Gómez-Lara, J, Brugaletta, S, Gómez-Menchero, A, Martín, P, Romero, M, García-Blas, S, Jiménez, M, Jiménez, VA, Bordes, P, Bayón, J, Salvatella, N, Alameda, M, Hyun-Lee, D, Trillo-Nouche, R, López-Benito, M, Frutos, A, Moreu, J, del Blanco, BG, Mohandes, M, Ojeda, FB, Hernández, FH, Pinar-Bermúdez, E, Jiménez-Quevedo, P, Rosselló, X, Pocock, S, Sabaté, M, Gómez-Hospital, JA, Comin-Colet, J, Gonzalo, N, Ortiz, AF, SUGAR Trial Investigators. Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial. HEART. 2025; 111(24)DOI:10.1136/heartjnl-2025-325773. PMID:40562528. IF:4.400(Q1/3D).
01/12/2025
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
Svennberg, E, Merino, JL, Andrade, J, Anselmino, M, Arbelo, E, Boersma, E, Boriani, G, Breithardt, G, Chung, MN, Chyou, J, Cohen, A, Nielsen, JC, Dichtl, W, Diederichsen, SZ, Dobrev, D, Doehner, W, Dworatzek, E, Fabritz, L, Filgueiras-Rama, D, Gimpelewicz, C, Hack, G, Hatem, S, Healey, J, Heidbuchel, H, Hijazi, Z, Holst, AG, Hove-Madsen, L, Jalife, J, van Leerdam, R, Linz, D, Lip, GYH, Lubitz, S, de Melis, M, Meyer, R, Orczykowski, M, Parwani, AS, Porta-Sanchez, A, de Potter, T, Ravens, U, Rienstra, M, Rillig, A, Rivard, L, Scherr, D, Schnabel, RB, Schotten, U, Simovic, S, Sinner, M, Sohns, C, Sommer, P, Steinbeck, G, Steven, D, Sultan, A, Thomalla, G, Toennis, T, Tzeis, S, Voigt, N, Wadhwa, M, Wakili, R, Witt, H, Goette, A, Kirchhof, P. Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. EUROPACE. 2025; 27(12)DOI:10.1093/europace/euaf318. PMID:41392710. IF:7.400(Q1/2D).
01/12/2025
Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions
Vizarraga, D, Marcos, M, Rotllan, N, Martín, J, Santos, D, Camacho, M, Soto, B, Velasco-Reniu, L, Guerra, P, Pareja, F, Collantes, M, Wu, WL, Rodríguez-Arce, I, Serrano, L, Piñol, J, Fita, I, Escolà-Gil, JC. Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-66129-5. PMID:41402265. IF:15.700(Q1/1D).
01/12/2025
Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients
Serra, E, Cantó, E, Gely, C, Pont, M, Trincado, J, Crespo, M, Vidal, S, Puig, L. Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2025; 145(12)DOI:. PMID:. IF:5.700(Q1/1D).
01/12/2025
Clinical and Economic Impact of Hybrid Closed-Loop Systems for T1 Diabetes Management in Spain
Khan-Miron, A, Syleouni, ME, Brusaferri, G, Nyffeler, M, Chico, A, Moreno-Fernandez, J, Beato-Víbora, PI. Clinical and Economic Impact of Hybrid Closed-Loop Systems for T1 Diabetes Management in Spain. Endocrine Practice. 2025; 31(12)DOI:10.1016/j.eprac.2025.08.002. PMID:40774615. IF:4.600(Q1/3D).
01/12/2025
Incidence and Survival of Colorectal Cancer in the United Kingdom From 2000 to 2021: A Population-Based Cohort Study
Pedregal-Pascual, P, Guarner-Argente, C, Tan, EH, Golozar, A, Duarte-Salles, T, Rosen, AW, Delmestri, A, Man, WY, Burn, E, Prieto-Alhambra, D, Newby, D. Incidence and Survival of Colorectal Cancer in the United Kingdom From 2000 to 2021: A Population-Based Cohort Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2025; 120(12)DOI:10.14309/ajg.0000000000003460. PMID:40167184. IF:7.600(Q1/1D).
01/12/2025
Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort
Betancor, D, Rial, MJ, Olaguibel, JM, Del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cárdaba, B, Cañas, JA, Domínguez-Ortega, J, Crespo-Leshman, A, Cruz, MJ, de la Fuente, AG, González-Barcalai, FJ, Luna-Portac, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Plaza, V, Quirce, S, Soto-Retes, L, Valverde-Monge, M, Sastre, J. Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.06.016. PMID:40707281. IF:9.200(Q1/1D).
01/12/2025
Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study
Rivas, DD, Martinez-Moragon, E, Plaza, V, Serrano, CC, Benchimol, C, Flores, HI, Sánchez-Cuéllar, S, Martinez-Pitarch, MD, Aracil, CF, Alonso, AT, Rebollo, JCS, Gambasica, ZV, Campos, RMD, Mulato, PT, Gimeno, IE, Laorden, D, Arismendi, E, Malanda, NM, Damia, AD, Galvan, MF, Dávila, I, Bobo, JOD, Cosio, BG, de Llano, LAP. Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.04.003. PMID:40348717. IF:9.200(Q1/1D).
01/12/2025
Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine
Pascual, MB, Zapata-Huizi, JJ, Ramos, D, Francesqui, J, Alsina-Restoy, X, Hernández-González, F, Sellares, J. Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 46(06)DOI:10.1055/a-2741-2030. PMID:41213628. IF:2.700(Q2/5D).
01/12/2025
Perioperative pembrolizumab in early-stage non-small-cell lung cancer (NSCLC): 5-year follow-up from the KEYNOTE-671 global study and Asian subgroup
Tsuboi, M, Wakelee, H, Spicer, JD, Gao, S, Liberman, M, Kato, T, Chen, KN, Dooms, C, Majem, M, Martinengo, GL, Bylicki, O, Abreu, DR, Halmos, B, Jones, DR, Chaft, J, Reck, M, Jense, E, Keller, SM, Samkari, A, Garassino, MC. Perioperative pembrolizumab in early-stage non-small-cell lung cancer (NSCLC): 5-year follow-up from the KEYNOTE-671 global study and Asian subgroup. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.10.607. PMID:. IF:65.400(Q1/1D).
01/12/2025
Impact of EBV status on the characteristics and prognosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients: Long-term experience from the GELTAMO group
Alós, DG, Sanchez, S, Dominguez, SR, Magnano, L, Barca, EG, Vicente, FD, Iacoboni, G, Manso, RG, Losada, CM, Huerga, S, Baumann, T, Izquierdo, AR, Bacelar, AG, Santaella, MP, Prieto, PG, De Villambrosia, SG, Bastos-Oreiro, M, Hernandez, AC, De Miguel, LB, Abellan, PF, Sturla, AL, Vidaller, PJP, Amutio, E, Toimil, FS, Pra, AM, Mico, M, De La Mano, EP, De La Cruz, B, Browne, S, Landwehr, M, Hernandez, I, Andreu, R, De La Cruz, J, Ubieto, AJ. Impact of EBV status on the characteristics and prognosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients: Long-term experience from the GELTAMO group. BLOOD. 2025; 146DOI:10.1182/blood-2025-472. PMID:. IF:23.100(Q1/1D).
01/12/2025
Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients
Moya, TA, Gay, MQS, Pasic, I, Gonzalez, MB, Gómez, MA, Salinas, AS, Camacho, JS, Alvaro, VI, Abdallah-Lefdil, Z, Navascues, JC, Gambarte, LP, Fernandez-Luis, S, Vega, L, Villar, S, Murillo, PB, Esquirol, A, Garcia, II, Mussetti, A, Lavilla-Rubira, E, Lopez, J, Filafferro, S, Balsalobre, P, Miguel, LBD, Michelis, F, Viswabandya, A, Mattsson, J, Alibhai, S, Rovira, M, Kim, D, Balari, AS, Kumar, R. Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients. BLOOD. 2025; 146DOI:10.1182/blood-2025-2652. PMID:. IF:23.100(Q1/1D).
01/12/2025
Matched unrelated vs. Haploidentical donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis-a randomized prospective european trial
Kroeger, N, Sanz, J, Stelljes, M, Martino, R, Rambaldi, A, Kwon, M, Sanchez-Guijo, F, Markova, M, Bondarenko, S, Eder, M, Heuser, M, Solano, C, Bonifazi, F, Wohlfarth, P, Massoud, R, Ayuk, F, Clausen, J, Choi, G, Greinix, H, Chiusolo, P, Patriarca, F, Gagelmann, N, Busca, A, Bug, G, Schroeder, T, Bethge, W, Glöckner, A, Hoelzer, D, Zey, S, Buchner, H, Wolschke, C. Matched unrelated vs. Haploidentical donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis-a randomized prospective european trial. BLOOD. 2025; 146DOI:10.1182/blood-2025-171. PMID:. IF:23.100(Q1/1D).
01/12/2025
Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results
Westin, J, Chavez, J, Schuster, SJ, Vucinic, V, Young, PA, Johnson, PC, Bramanti, S, Rambaldi, A, Meijide, JB, Kato, K, Sancho, JM, Kwon, M, Solano, C, Fleming, S, Dahiya, S, Garcia-Sancho, AM, Ramos, PM, Pearson, D, Diallo, S, Zia, A, Segura, E, Masood, A, Barba, P. Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results. BLOOD. 2025; 146DOI:10.1182/blood-2025-670. PMID:. IF:23.100(Q1/1D).
01/12/2025
Phase 1 evaluation of the safety and efficacy of rapcabtagene autoleucel (YTB323) in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)
Barba, P, Rambaldi, A, Boissel, N, Doki, N, Blaise, D, Ciceri, F, Meijide, JB, Kwon, M, Fleming, S, Goñi, CB, Teshima, T, Kato, K, Balsat, M, Jaeger, U, Shune, L, Ramos, PM, Pearson, D, Corcoran, J, Zia, A, Foster, M, Masood, A, Dickinson, M. Phase 1 evaluation of the safety and efficacy of rapcabtagene autoleucel (YTB323) in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). BLOOD. 2025; 146DOI:10.1182/blood-2025-811. PMID:. IF:23.100(Q1/1D).
01/12/2025
Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathy
Hinson, SR, Gupta, P, Paramasivan, NK, Dyck, PJB, Lennon, VA, Lachance, DH, Knight, AM, Rezk, M, Karsten, C, LaFrance-Corey, RG, Staff, NP, Hrstka, SC, Wu, JC, Klein, CJ, Zekeridou, A, Mckeon, A, Pittock, SJ, Lleixà, C, Querol, L, Dasari, S, Mills, JR, Dubey, D. Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathy. EBioMedicine. 2025; 122DOI:10.1016/j.ebiom.2025.106053. PMID:41337934. IF:10.800(Q1/1D).
01/12/2025
Peripheral Nerve Society Training Grant Program: An Exciting Opportunity Not to Be Missed
Alberti, P, Querol, L. Peripheral Nerve Society Training Grant Program: An Exciting Opportunity Not to Be Missed. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(4)DOI:10.1111/jns.70076. PMID:41236205. IF:3.200(Q2/4D).
01/12/2025
ORGANIZATIONAL SUPPORT IN ADOPTING NEW TREATMENTS FOR GENERALIZED MYASTHENIA GRAVIS
Armangué, T, Gómez-Ballesteros, R, Querol, L, Gutiérrez-Gutiérrez, G, Sotoca, J, Luque, AA, Villaverde, R, Reyes, V, Salas, E, Diaz, P, Maurino, J, Cortés-Vicente, E. ORGANIZATIONAL SUPPORT IN ADOPTING NEW TREATMENTS FOR GENERALIZED MYASTHENIA GRAVIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/12/2025
Combining Life History Calendars and Ecological Momentary Assessment for Evaluating Everyday Stress and Its Impact on Mental Health in Healthy Adults: Longitudinal Study
Chavarría-Elizondo, P, Tortella-Feliu, M, Fortea, L, De la Peña-arteaga, V, Juaneda-Seguí, A, Martínez-Zalacaín, I, Vilajosana, E, Radua, J, Shackman, AJ, Soriano-Mas, C, Fullana, MA. Combining Life History Calendars and Ecological Momentary Assessment for Evaluating Everyday Stress and Its Impact on Mental Health in Healthy Adults: Longitudinal Study. STRESS AND HEALTH. 2025; 41(6)DOI:10.1002/smi.70128. PMID:41307189. IF:2.700(Q2/4D).
01/12/2025
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease
Andersen, OM, de Waal, MWJ, Monti, G, Tesi, N, Jensen, AMG, De Geus, C, van Spaendonk, R, Vogel, M, Ahmad, S, Amin, N, Amouyel, P, Beecham, GW, Bellenguez, C, Berr, C, Bis, JC, Boland, A, Bossù, P, Bouwman, F, Bras, J, Charbonnier, C, Clarimon, J, Cruchaga, C, Daniele, A, Dartigues, JF, Debette, S, Deleuze, JF, Denning, N, Destefano, AL, Dols-Icardo, O, van Duijn, CM, Farrer, LA, Fernández, MV, van der Flier, WM, Fox, NC, Galimberti, D, Genin, E, Gille, JJP, Grenier-Boley, B, Grozeva, D, Guen, YL, Guerreiro, R, Haines, JL, Holmes, C, Hummerich, H, Ikram, MA, Ikram, MK, Kawalia, A, Kraaij, R, Lambert, JC, Lathrop, M, Lemstra, AW, Lleo, A, Myers, RM, Mannens, MMAM, Marshall, R, Martin, ER, Masullo, C, Mayeux, R, Mead, S, Mecocci, P, Meggy, A, Mol, MO, Nacmias, B, Naj, AC, Napolioni, V, Cochran, JN, Nicolas, G, Pasquier, F, Pastor, P, Pericak-Vance, MA, Pijnenburg, YAL, Piras, F, Quenez, O, Ramirez, A, Raybould, R, Redon, R, Reinders, MJT, Richard, AC, Riedel-Heller, SG, Rivadeneira, F, van Rooij, JGJ, Rousseau, S, Ryan, NS, Sanchez-Juan, P, Schellenberg, GD, Scheltens, P, Schott, JM, Seshadri, S, Sie, D, Sims, R, Sistermans, EA, Sorbi, S, van Swieten, JC, Tijms, B, Uitterlinden, AG, Visser, PJ, Wagner, M, Wallon, D, Wang, LS, Williams, J, Yokoyama, JS, Zarea, A, van der Lee, SJ, Olsen, JG, Hulsman, M, Holstege, H. Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease. Molecular Neurodegeneration. 2025; 20(1)DOI:10.1186/s13024-025-00907-z. PMID:41327266. IF:17.500(Q1/1D).
01/12/2025
An International Course on Intraoperative Ultrasound in Neurosurgery: Evaluation of a Multicenter, Hands-On Course in Promoting Familiarity and Use of Intraoperative Ultrasound in Neurosurgery
Mazurek, MH, Bassa, MJ, Padayachy, L, Wetzel, EA, Moiyadi, A, Perin, A, De Quintana, C, Prada, F, Nahed, B, DiMeco, F, Unsgard, G. An International Course on Intraoperative Ultrasound in Neurosurgery: Evaluation of a Multicenter, Hands-On Course in Promoting Familiarity and Use of Intraoperative Ultrasound in Neurosurgery. World Neurosurgery. 2025; 204DOI:10.1016/j.wneu.2025.124524. PMID:41033596. IF:2.100(Q2/4D).
01/12/2025
Long-term efficacy of migalastat in females with Fabry disease
Kallish, S, Camporeale, A, Hopkin, RJ, Jovanovic, A, Nordbeck, P, Veleva-Rotse, BO, Krusinska, E, Torra, R. Long-term efficacy of migalastat in females with Fabry disease. JOURNAL OF MEDICAL GENETICS. 2025; 62(12)DOI:10.1136/jmg-2024-110596. PMID:40897525. IF:3.700(Q2/3D).
01/12/2025
Association of in utero exposure to phthalate and DINCH metabolites with placental DNA methylation
Vespalcova, H, Knox, B, Sakhi, AK, Thomsen, C, Aguilar-Lacasana, S, Cosin-Tomas, M, Gomez-Herrera, L, Garcia, OS, Llurba, E, Gomez-Roig, MD, Sunyer, J, Dadvand, P, Bustamante, M, Vrijheid, M. Association of in utero exposure to phthalate and DINCH metabolites with placental DNA methylation. ENVIRONMENT INTERNATIONAL. 2025; 206DOI:10.1016/j.envint.2025.109946. PMID:41275763. IF:9.700(Q1/1D).
01/12/2025
Prenatal phenol exposure and child behaviour: insights into the hypothalamic-pituitary-adrenal axis from two prospective mother-child cohorts
Rolland, M, Bustamante, M, Jedynak, P, Thomsen, C, Sakhi, AK, Foraster, M, Gascon, M, Gómez-Roig, MD, Llurba, E, Rivas, I, Ouellet-Morin, I, Ferrer, M, Morillas, A, Carras, S, Bayat, S, Lyon-Caen, S, Pozo, OJ, Vrijheid, M, Sunyer, J, Slama, R, Dadvand, P, Philippat, C. Prenatal phenol exposure and child behaviour: insights into the hypothalamic-pituitary-adrenal axis from two prospective mother-child cohorts. Lancet Planetary Health. 2025; 9(12)DOI:10.1016/j.lanplh.2025.101330. PMID:41386271. IF:21.600(Q1/1D).
01/12/2025
Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD
Miravitlles, M, Calle, M, Molina, J, Almagro, P, Gomez, JT, Trigueros, JA, Sánchez-Angarita, E, Cosio, BG, Casanova, C, López-Campos, JL, Riesco, JA, Simonet, P, Rigau, D, Iskakova, A, Sanz, MP, Sobradillo, P, Alcázar-Navarrete, B, Garin, N, Soler-Cataluña, JJ. Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.10.008. PMID:41198528. IF:9.200(Q1/1D).
01/12/2025
Aligning research funding and the production of useful evidence to reduce research waste
Meza, N, Madrid, E, Urrútia, G, Clarke, M. Aligning research funding and the production of useful evidence to reduce research waste. Bmj Evidence-Based Medicine. 2025; 30(6)DOI:10.1136/bmjebm-2025-114324. PMID:41326283. IF:7.600(Q1/1D).
01/12/2025
ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa
Grau-Pérez, M, Ciudad, C, Molina-Leyva, A, Martorell, A, Vilarrasa, E, Albert, I, Garcias-Ladaria, J, Melgosa, FJ, Rivera, R, Campos, M, Haselgruber, S, Ochando, G, Pascual, JC, García-Ruiz, R, Alfageme, F. ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. DERMATOLOGY. 2025; 241(5-6)DOI:10.1159/000546647. PMID:40587963. IF:2.700(Q2/4D).
01/12/2025
REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS
Ferrer, AL, Belinchón, I, Serra, MC, Clua, MG, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/12/2025
UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS
Ferrer, AL, Belinchón, I, Serra, MC, Martínez, LE, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/12/2025
HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS
Strober, B, Puig, L, Lebwohl, MG, Lakshminarasimhan, B, Khan, SA, Pillai, N, Kappelhoff, B, Weatherill, A, Warren, RB. HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/12/2025
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group
Li, R, Hensley, PJ, Babjuk, M, Bukavina, L, Psutka, SP, Lerner, SP, O'Donnell, MA, Lotan, Y, Bree, KK, Redorta, JP, McConkey, DJ, Lee, BH, Mariappan, P, Mertens, LS, Soloway, MS, Svatek, RS, Tan, WS, Williams, SB, Gupta, S, Buckley, R, Kamat, AM. Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group. European Urology Oncology. 2025; 8(6)DOI:10.1016/j.euo.2025.08.003. PMID:41076366. IF:9.300(Q1/1D).
01/12/2025
Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer
Zamora, V, Garin, O, Suárez, JF, Guedea, F, Pont, A, Pardo, Y, Goñi, A, Mariño, A, Hervás, A, Herruzo, I, Cabrera, P, Sancho, G, León, JPD, Macías, V, Gutiérrez, C, Castells, M, Ferrer, M. Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer. European Urology Open Science. 2025; 82DOI:10.1016/j.euros.2025.10.007. PMID:41311640. IF:4.500(Q1/2D).